Publications by authors named "Carol Iredale"

Claim this Profile
D
Double-blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 diabetes: The CompoSIT-M study.
Juan P Frias, Zachary Zimmer, Raymond L H Lam, Guillermo Amorin, Catherine Ntabadde, Carol Iredale

Diabetes Obes Metab· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind trial evaluating the efficacy and safety of monotherapy with the once-weekly dipeptidyl peptidase-4 inhibitor omarigliptin in people with type 2 diabetes.
Philip Home, R Ravi Shankar, Ira Gantz, Carol Iredale, Edward A O'Neill

Diabetes Res Clin Pract· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy.
Yehuda Handelsman, Brett Lauring, Ira Gantz, Carol Iredale, Edward A O'Neill

Curr Med Res Opin· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Prohibited Medication, a Potentially Overlooked Confounder in Clinical Trials: Omarigliptin (Once-weekly DPP-4 Inhibitor) Monotherapy Trial in 18- to 45-year-olds.
Ira Gantz, Liubov Sokolova, Lokesh Jain, Carol Iredale, Edward A O'Neill

Clin Ther· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis